TITLE

Seroprevalence of hepatitis B and C virus infection among patients attending serology laboratory of Gondar University Hospital

AUTHOR(S)
Tesfa, Habtie; Biadgo, Belete; Getachew, Fasika; Tegegne, Kifle; Yismaw, Gizachew; Muluye, Dagnachew
PUB. DATE
June 2013
SOURCE
BMC Research Notes;2013, Vol. 6 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Hepatitis B virus (HBV) and hepatitis C virus (HBV) infections accounts for substantial proportions of the world wide liver disease. The two hepatotropic virus share common modes of transmission and their co-infection are common. Patients with dual HBV and HCV infection have more severe liver disease and are at increased risk of progression to hepatic cell carcinoma. This study was aimed to assess the prevalence of HBV and HCV among patients attending serology laboratory of Gondar University Teaching Hospital. Methods: A retrospective study was conducted from January 2007 to December 2011 at serology laboratory of Gondar University Teaching Hospital. Data were cross checked for completeness, entered and analyzed using SPSS version 16 statistical package. Results: From the total of 2,684 clinicaly suspected hepatitis patients, 563 (20.98%) were positive for HBsAg and anti-HCV test. Of all, 14.4% were seropositive for HBV (male= 7.89% female=6.27%) (p-value=0.011) while 12.4% were seropositive for HCV (male =7.6% and female=4.13%) (p-value<0.001). The co-incidence of HBV and HCV were found to be 36 (6.39%) (male=3.9% and female=2.4%) (p-value <0.001). Majority of HBV (30.2%) and HCV (30.7%) infections were detected among age group of 25-34 years old (p-value=0.36) and 15-24 years old (p-value<0.001) respectively. Conclusion: The overall prevalence of HBV and HCV is high. Males and younger age groups were more affected. Community awareness about the transmission and prevention of viral hepatitis infection should be strengthened by giving health education and herd immunization.
ACCESSION #
88014068

 

Related Articles

  • Viral hepatitis in patients hospitalized in two teaching hospitals, Tehran, Iran. Talebi-Taher, Mahshid; Mohit, Mohammad; Avanessians, Thelma Boghous // Iranian Journal of Clinical Infectious Diseases;Winter2010, Vol. 5 Issue 1, p25 

    Background: Viral hepatitis is a systemic infection affecting the liver predominantly. Almost all cases of acute viral hepatitis are caused by one of five viral agents: HAV, HBV, HCV, HDV and HEV. The present study aimed to find out the frequency of various forms of viral hepatitis (HAV, HBV,...

  • Hepatitis G virus. Reshetnyak, Vasiliy Ivanovich; Karlovich, Tatiana Igorevna; Ilchenko, Ljudmila Urievna; Mondelli, Mario U.; Reshetnyak, Vasiliy I. // World Journal of Gastroenterology;8/14/2008, Vol. 14 Issue 30, p4725 

    A number of new hepatitis viruses (G, TT, SEN) were discovered late in the past century. We review the data available in the literature and our own findings suggesting that the new hepatitis G virus (HGV), disclosed in the late 1990s, has been rather well studied. Analysis of many studies...

  • A brighter future in the fight against hepatitis.  // Nature Medicine;Jul2013, Vol. 19 Issue 7, p791 

    The article looks at efforts to prevent and treat viral hepatitis worldwide. The World Health Organization (WHO) has made July 28 the official World Hepatitis Day to increase public awareness of the disease. The prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) and their role in...

  • HBV and HCV seroprevalence and their correlation with CD4 cells and liver enzymes among HIV positive individuals at University of Gondar Teaching Hospital, Northwest Ethiopia. Wondimeneh, Yitayih; Alem, Meseret; Asfaw, Fanaye; Belyhun, Yeshambel // Virology Journal;2013, Vol. 10 Issue 1, p1 

    Background: The co-existence of viral hepatitis caused by HBV and HCV become common causes of severe liver complication and immunological impairment among HIV infected individuals. The aim of this study was to assess the seroprevalence of HBV and HCV and their correlation with CD4 and liver...

  • Surveillance for Acute Viral Hepatitis -- United States, 2007. Daniels, Danni; Grytdal, Scott; Wasley, Annemarie // MMWR Surveillance Summaries;5/22/2009, Vol. 58 Issue SS-3, preceding p1 

    Problem: In the United States, acute viral hepatitis most frequently is caused by infection with any of three distinct viruses: hepatitis A virus (HAV), hepatitis B virus (HBV), or hepatitis C virus (HCV). These unrelated viruses are transmitted through different routes and have different...

  • Orthopedic Surgeons and Hepatitis. D'Ambrosia, Robert; Kilpatrick, Jennifer A. // Orthopedics;Jul2004, Vol. 27 Issue 7, p702 

    The article presents the author's views on viral hepatitis. This type of hepatitis is considered the major cause of liver disease. Hepatitis B virus was discovered after World War II. Vaccine for Hepatitis B was introduced and has significantly reduced the rate of infection in the U.S....

  • Immunology of hepatitis B virus and hepatitis C virus infection. Rehermann, Barbara; Nascimbeni, Michelina // Nature Reviews Immunology;Mar2005, Vol. 5 Issue 3, p215 

    More than 500 million people worldwide are persistently infected with the hepatitis B virus (HBV) and/or hepatitis C virus (HCV) and are at risk of developing chronic liver disease, cirrhosis and hepatocellular carcinoma. Despite many common features in the pathogenesis of HBV- and HCV-related...

  • PREVALENCE OF PARENTERALLY TRANSMITTED HEPATITIS VIRUSES IN CLINICALLY DIAGNOSED CASES OF HEPATITIS. Arora, D. R.; Sehgal, R.; Gupta, N.; Yadav, A.; Mishra, N.; Siwach, S. B. // Indian Journal of Medical Microbiology;Jan2005, Vol. 23 Issue 1, p44 

    Hepatitis B virus (HBV) is the most important causative agent of blood borne hepatitis in humans. Hepatitis D Virus (HDV) infection occurs either as a coinfection or superinfection in HBV carriers. Hepatitis C virus (HCV) is the major cause of transfusion non-A, non-B hepatitis and continues to...

  • Korean Medicinal Plant Extracts Exhibit Antiviral Potency Against Viral Hepatitis. Jacob, James R.; Korba, Brent E.; Jung Eun You; Tennant, Bud C.; Young-Ho Kim // Journal of Alternative & Complementary Medicine;Dec2004, Vol. 10 Issue 6, p1019 

    Investigation of natural ethnopharmacologic extracts exhibiting antiviral potential may lead to the discovery of new therapeutics for the treatment of chronic viral hepatitis infections. Traditional Koreanmedicinal herbs have been identified that exhibit potency against hepatitis B virus (HBV)...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics